These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21935965)

  • 1. Pharmacokinetic profile of SKP-1041, a modified release formulation of zaleplon.
    Greenblatt DJ; Harmatz JS; Walsh JK; Luthringer R; Staner L; Otmani S; Nedelec JF; Francart C; Parent SJ; Staner C
    Biopharm Drug Dispos; 2011 Dec; 32(9):489-97. PubMed ID: 21935965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.
    Greenblatt DJ; Harmatz JS; von Moltke LL; Ehrenberg BL; Harrel L; Corbett K; Counihan M; Graf JA; Darwish M; Mertzanis P; Martin PT; Cevallos WH; Shader RI
    Clin Pharmacol Ther; 1998 Nov; 64(5):553-61. PubMed ID: 9834048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics and pharmacodynamics of zaleplon delivered as a thermally generated aerosol in a single breath to volunteers.
    Avram MJ; Spyker DA; Kehne JH; Cassella JV
    J Clin Pharmacol; 2013 Feb; 53(2):140-50. PubMed ID: 23436259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zaleplon pharmacokinetics and absolute bioavailability.
    Rosen AS; Fournié P; Darwish M; Danjou P; Troy SM
    Biopharm Drug Dispos; 1999 Apr; 20(3):171-5. PubMed ID: 10211871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboons.
    Ator NA
    Drug Alcohol Depend; 2000 Dec; 61(1):55-68. PubMed ID: 11064184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid disappearance of zaleplon from breast milk after oral administration to lactating women.
    Darwish M; Martin PT; Cevallos WH; Tse S; Wheeler S; Troy SM
    J Clin Pharmacol; 1999 Jul; 39(7):670-4. PubMed ID: 10392321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance.
    Paul MA; Gray G; Kenny G; Pigeau RA
    Aviat Space Environ Med; 2003 Dec; 74(12):1263-70. PubMed ID: 14692469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychomotor effects of zaleplon and thioridazine coadministration.
    Hetta J; Broman JE; Darwish M; Troy SM
    Eur J Clin Pharmacol; 2000 Jun; 56(3):211-7. PubMed ID: 10952475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zaleplon loaded bi-layered chronopatch: A novel buccal chronodelivery approach to overcome circadian rhythm related sleep disorder.
    Farag MM; Abd El Malak NS; Yehia SA
    Int J Pharm; 2018 May; 542(1-2):117-124. PubMed ID: 29526622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance.
    Weinling E; McDougall S; Andre F; Bianchetti G; Dubruc C
    Fundam Clin Pharmacol; 2006 Aug; 20(4):397-403. PubMed ID: 16867025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon.
    Stone BM; Turner C; Mills SL; Paty I; Patat A; Darwish M; Danjou P
    Br J Clin Pharmacol; 2002 Feb; 53(2):196-202. PubMed ID: 11851645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem.
    Drover D; Lemmens H; Naidu S; Cevallos W; Darwish M; Stanski D
    Clin Ther; 2000 Dec; 22(12):1443-61. PubMed ID: 11192136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening.
    Zammit GK; Corser B; Doghramji K; Fry JM; James S; Krystal A; Mangano RM
    J Clin Sleep Med; 2006 Oct; 2(4):417-23. PubMed ID: 17557470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of an interaction between ibuprofen and zaleplon.
    Sanchez Garcia P; Carcas A; Zapater P; Rosendo J; Paty I; Leister CA; Troy SM
    Am J Health Syst Pharm; 2000 Jun; 57(12):1137-41. PubMed ID: 10911512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zaleplon and triazolam in humans: acute behavioral effects and abuse potential.
    Rush CR; Frey JM; Griffiths RR
    Psychopharmacology (Berl); 1999 Jul; 145(1):39-51. PubMed ID: 10445371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening.
    Danjou P; Paty I; Fruncillo R; Worthington P; Unruh M; Cevallos W; Martin P
    Br J Clin Pharmacol; 1999 Sep; 48(3):367-74. PubMed ID: 10510148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of human metabolism of the sedative-hypnotic zaleplon using chimeric mice transplanted with human hepatocytes.
    Tanoue C; Sugihara K; Uramaru N; Tayama Y; Watanabe Y; Horie T; Ohta S; Kitamura S
    Xenobiotica; 2013 Nov; 43(11):956-62. PubMed ID: 23651075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons.
    Ator NA; Weerts EM; Kaminski BJ; Kautz MA; Griffiths RR
    Drug Alcohol Depend; 2000 Dec; 61(1):69-84. PubMed ID: 11064185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of a new once-daily controlled-release sarpogrelate hydrochloride compared with immediate-release formulation and the effect of food.
    Kim TE; Kim JR; Jung JA; Kim MJ; Lee SY; Ko JW; Jung WT; Choi YW; Lee HJ; Kim SH; Huh W
    J Clin Pharm Ther; 2014 Apr; 39(2):192-5. PubMed ID: 24325365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of insomnia with zaleplon, a novel sleep medication.
    Doghramji PP
    Int J Clin Pract; 2001 Jun; 55(5):329-34. PubMed ID: 11452683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.